Small-cap companies are riskier than large-cap companies, as they can offer better returns over the long-term. Still, they do not have the resources of large-cap companies, making them more susceptible to bearish sentiments.
Any adverse movement in the foreign exchange price may impact the company's financial performance. Also, these products are exposed to risks associated with COVID-19, which might disrupt supply and impact the company's sales.
Kalkine healthcare report is generated every week.